Skip to main content
Clinical Trials/NCT04881097
NCT04881097
Withdrawn
N/A

Cognitive Function and Health-related Quality of Life After Neuro-intensive Care: An Observational Multicenter Cohort Study

Rigshospitalet, Denmark0 sitesAugust 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acute Brain Injury
Sponsor
Rigshospitalet, Denmark
Primary Endpoint
Change in Global cognitive function
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

The study will provide information on cognitive impairment and Health related quality of life in patients surviving 12 months after acute brain injury, generate a hypothesis of useful variables to predict cognitive impairment or low levels of HRQoL, and potentially inform interventions for the prevention and treatment of cognitive impairment following neuro-ICU stay.

Detailed Description

The aim is to 1) measure the frequency and extent of cognitive impairment after acute brain injury at six and 12-months after neuro-Intensive care unit (ICU) admission 2) explore the association between cognitive impairment at six and 12 months after ICU admission with the following potential risk factors: duration of ICU delirium (days), duration of sepsis (days), duration of post traumatic amnesia (days) and the severity of brain injury (initial Glasgow Coma Scale , 3) describe Health related quality of life, functional disability and frailty at six and 12 after ICU admission and 4) explore the association between the functional disability, frailty and health-related quality of life at 12 months after ICU admission

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
August 1, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kirsten Moller

Professor

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Traumatic brain injury
  • Spontaneous intracranial hemorrhage
  • Ischemic stroke
  • An anticipated stay in the neuro-ICU for 48 hours or longer.

Exclusion Criteria

  • Persistent coma defined as Richmond Agitation-Sedation Scale (RASS) -5 to -3 throughout the neuro-ICU stay
  • Congenital brain injury
  • Suspected pre-existing Cognitive impairment (Informant Questionnaire on cognitive decline in the elderly (IQCODE): 3.3 or more) (regardless of cause)
  • Permanent residence outside Denmark
  • Inability to communicate in Danish

Outcomes

Primary Outcomes

Change in Global cognitive function

Time Frame: from baseline to 12 months after ICU admission

measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15). Higher scores indicate better cognitive functioning.

Change in Executive function

Time Frame: from baseline to 12 months after ICU admission

measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function

Secondary Outcomes

  • Change in Disability after head injury/nontraumatic acute brain insults II(from baseline to 12 months after ICU admission)
  • Change in Frailty(baseline to 12 months after ICU admission)
  • Change in Health related quality of life after brain injury(from baseline to 12 months after ICU admission)
  • Delirium(during the procedure (ICU stay) up to 30 days)
  • Change in Disability after head injury/nontraumatic acute brain insults I(from baseline to 12 months after ICU admission)

Similar Trials